Valeant shares drop as CEO returns, it cancels fourth-quarter report

[ahlam1399]

Valeant shares drop as CEO returns, it cancels fourth-quarter report
(Reuters) - Shares in embattled drugmaker Valeant Pharmaceuticals International Inc fell as much as 21 percent on Monday, a day after the company canceled the release of fourth-quarter earnings, withdrew 2016 financial guidance and said its chief executive had returned from medical leave.
http://i0.wp.com/reuters.us.feedsportal.com/c/35217/f/654199/s/4dee6b3f/sc/28/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/businessNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/businessNews?a=3ubREZyeDxI:ZnkoMdIi3fA:yIl2AUoC8zA ) http://feeds.feedburner.com/~ff/reuters/businessNews?i=3ubREZyeDxI:ZnkoMdIi3fA:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/businessNews?a=3ubREZyeDxI:ZnkoMdIi3fA:F7zBnMyn0Lo ) http://feeds.feedburner.com/~ff/reuters/businessNews?i=3ubREZyeDxI:ZnkoMdIi3fA:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/businessNews?a=3ubREZyeDxI:ZnkoMdIi3fA:V_sGLiPBpWU )
http://feeds.feedburner.com/~r/reuters/businessNews/~4/3ubREZyeDxI